2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

BACKGROUND: The adjuvanted recombinant zoster vaccine (RZV) is efficacious in preventing herpes zoster in adults ≥ 50 years. The current study investigates whether the vaccinees’ quality of life (QoL) and physical functioning (PF) are impacted by local and systemic reactions due to RZV. In a previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne, Oostvogels, Lidia, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810498/
http://dx.doi.org/10.1093/ofid/ofz360.2455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810498/
http://dx.doi.org/10.1093/ofid/ofz360.2455

Ejemplares similares